Journal article icon

Journal article

The significance of FOXP1 in diffuse large B-cell lymphoma

Abstract:

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of mature B-cell lymphoma. While the majority of patients are cured with immunochemotherapy incorporating the anti-CD20 monoclonal antibody rituximab (R-CHOP), relapsed and refractory patients still have a dismal prognosis. DLBCL subtypes including an aggressive activated B-cell-like (ABC) and a more favourable prognosis germinal centre-like (GCB) DLBCL have been identified by gene expression profiling and are characterised by d...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1080/10428194.2016.1228932

Authors


More by this author
Department:
Oxford, MSD, RDM, RDM Clinical Laboratory Sciences
More by this author
Department:
Oxford, MSD, RDM, RDM Clinical Laboratory Sciences
Publisher:
Taylor and Francis Publisher's website
Journal:
Leukemia and Lymphoma Journal website
Volume:
58
Issue:
5
Pages:
1037-1051
Publication date:
2016-09-05
Acceptance date:
2016-08-23
DOI:
EISSN:
1029-2403
ISSN:
1042-8194
Pubs id:
pubs:641717
URN:
uri:0af296cc-ed42-4dea-8457-9dc26cb1c00a
UUID:
uuid:0af296cc-ed42-4dea-8457-9dc26cb1c00a
Local pid:
pubs:641717

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP